Abstract
Recent studies have noted an increased risk of low energy subtrochanteric and femoral shaft fractures termed “atypical femur fractures” (AFFs) associated with long-term bisphosphonate use. As such, many clinicians have begun recommending a “drug holiday” to reduce the risks associated with long-term bisphosphonate use. We present two cases of AFFs occurring during a 4-year or greater drug holiday following long-term bisphosphonate use. These findings highlight the need to reevaluate optimal bisphosphonate therapy duration, dosage, as well as initiation and duration of a drug holiday with continued monitoring in the prevention of AFFs.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1755-1758 |
| Number of pages | 4 |
| Journal | Osteoporosis International |
| Volume | 26 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 17 2015 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Atypical femur fractures
- Bisphosphonates
- Drug holiday
- Osteoporosis
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
Fingerprint
Dive into the research topics of 'Atypical femur fracture during bisphosphonate drug holiday: a case series'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS